{
    "title": "AbbVie's blood cancer combo therapy fails in late-stage study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12575177/AbbVies-blood-cancer-combo-therapy-fails-late-stage-study.html",
    "date": "2023-09-29",
    "keywords": [
        "combination",
        "blood",
        "cancer",
        "company",
        "therapy",
        "dexamethasone",
        "friday",
        "latestage",
        "study",
        "form",
        "rate",
        "disease",
        "type",
        "myeloma",
        "survival",
        "period",
        "pomalyst",
        "disappearance",
        "reduction",
        "tumor",
        "size",
        "pomalystdexamethasone",
        "trial",
        "endpoint",
        "health",
        "future",
        "head",
        "oncology",
        "hematology",
        "statement",
        "multiple",
        "secondmost",
        "world",
        "plasma",
        "bone",
        "marrow",
        "production",
        "venclyxto",
        "abbvie",
        "roche",
        "unit",
        "genentech",
        "country",
        "reporting",
        "mariam",
        "sunny",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}